Vimarsana
Biggest News Aggregation in the World

Metastatic Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Metastatic Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Metastatic Prostate Today - Breaking & Trending Today

World Metastatic Prostate Cancer Drug Landscape Research - Vimarsana News

World Metastatic Prostate Cancer Drug Landscape Research

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The

Palliative Care for Metastatic Prostate Cancer: Symptom Relief and Support - Vimarsana News

Palliative Care for Metastatic Prostate Cancer: Symptom Relief and Support

Learn about medications, surgery, radiation, exercise, and other therapies and strategies for symptom relief from advanced prostate cancer.

Novartis Pharma AG: Novartis PluvictoTM shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer - Vimarsana News

Novartis Pharma AG: Novartis PluvictoTM shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer

Ad hoc announcement pursuant to Art. 53 LR Phase III PSMAfore trial with PluvictoTM met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA-positive mCRPC who have been treated

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza granted FDA priority review for PROpel - Vimarsana News

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza granted FDA priority review for PROpel

Investegate announcements from AstraZeneca PLC, Lynparza granted FDA priority review for PROpel

Blue Earth Diagnostics: Independent Clinical Studies Published Regarding Performance of Axumin (Fluciclovine F 18) PET Imaging in Patients with Recurrent Prostate Cancer Undergoing Androgen Deprivation Therapy (ADT) - Vimarsana News

Blue Earth Diagnostics: Independent Clinical Studies Published Regarding Performance of Axumin (Fluciclovine F 18) PET Imaging in Patients with Recurrent Prostate Cancer Undergoing Androgen Deprivation Therapy (ADT)

- Recently published retrospective studies in Urologic Oncology and Tomography assessed the impact of Androgen Deprivation Therapy (ADT) on Axumin PET imaging - Blue Earth Diagnostics, a Bracco company